Clinical research participants play an invaluable role in the development of innovative new therapies. It is imperative that their contribution is duly recognized and that appropriate safeguards are implemented to protect them. To that end, Midlands IRB’s board members are a group of individuals dedicated to a thorough review process with a focus on strengthening protections for research participants.

Members of our
board include:
  • Doctors of Philosophy (PhD), Science
  • Doctors of Pharmacy (PharmD)
  • Doctors of Medicine (MD)
  • Juris Doctors (JD)
  • Registered Nurses (RN)
  • Certified IRB Professionals (CIP)
Our review board
also provides:
  • Full compliance with all relevant U.S. regulations
  • Dedicated in-house expedited review team for qualified submissions
  • Electronic access to review documentation